Didn't say I don't want you to address it. You'll do what
Didn't say I don't want you to address it. You'll do what you always do when caught spouting your bs. Dodge and deny.
I'm saying I don't care if you address it. You know you did it.
And all of you complaints about the company you have never invested in for the last 7 years have all been addressed and explained.
You, of course will deny this also.
All that matters at this point is that they prove what they say they have works.
This is what actual shareholders care about.
I'm not worried about that in the least bit.
Seafarer Exploration (SFRX) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Top 5 Most Recently Viewed Articles
Important Information for Petco Investors Petco Health and Wellness Company, Inc. (NASDAQ: WOOF) has been a significant part of the investment landscape in recent times. Investors who purchased securities of Petco within a specified timeframe should take careful note of an important upcoming deadline that may impact their claims. The Rosen Law Firm, known for advocating...
Continue Reading
Vertafore's Recent Industry Recognitions Vertafore, a prominent name in the InsurTech landscape, has recently celebrated its inclusion on both the 2024 InsurTech100 list and the PropertyCasualty360 Insurance Luminaries Class of 2024, showcasing its dedication to innovation in the insurance sector. Recognition by InsurTech100 For the second consecutive year, Vertafore has...
Continue Reading
Shifting Perceptions Around Higher Education In recent years, a significant change has occurred in the way many Americans view the value of higher education, particularly four-year college degrees. A recent survey indicates that nearly two-thirds of registered voters now believe that obtaining such a degree may not be worth the financial burden it often entails. Poll...
Continue Reading
Alkane Resources Limited Announces Strong Q1 2026 Results Alkane Resources Limited (ASX: ALK, OTC: ALKEF, TSX: ALK) has shared remarkable financial results for the first quarter ending September 30, 2025. Following a recent merger with Mandalay Resources, the company has seen significant growth and progress. Key Highlights from Q1 2026 The condensed and consolidated...
Continue Reading
Spectral Medical Shares Updates on the Tigris Trial's Progress In a notable development, Spectral Medical Inc. (TSX: EDT), a company specializing in advanced therapeutics for sepsis and septic shock, has provided an important update regarding its Tigris trial. This Phase 3 study focuses on evaluating the efficacy of Polymyxin B Hemoperfusion (PMX) in treating adults...
Continue Reading
